InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Sands Capital Life Sciences Pulse Fund II, L.P.. Officer active across 1 company, notably Inhibikase Therapeutics, Inc.. Aggregated, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €2.6m. Activity tracked since 21 November 2025. The latest transaction was disclosed on 21 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration